Description: The cell and gene therapy marketplace is quickly evolving and continues to grow as a risk concern for governments, health plans, stop loss insurers and reinsurers. In this webinar, we discuss currently approved tissue, cell and gene therapies, the near-term pipeline, uptake considerations, case management processes, plan document and contract considerations, risk mitigation processes and programs, and network considerations.

Description: The article summarizes the results of the 2024 Life Reinsurance Survey of Individual Life and Group Life business written in the traditional life reinsurance markets of the United States and Canada. The article summarizes the new business volume written in 2024 and 2023 as well as the volume of ceded reinsurance in force at year-end 2024 and 2023.